This unique book provides a thorough overview of developing molecular cancer diagnostic assays, which are the prerequisites for optimal solutions within personalized cancer medicine. The book takes the reader through definitions of the pharmacodiagnostic concept, historical perspectives of the early steps into molecular cancer diagnostics linked to therapy, the basis of different diagnostic molecular techniques, ongoing research, drug-diagnostic co-development, assay validation, clinical trial methodology, regulatory issues around pharmacodiagnostics and future aspects within personalized cancer medicine.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Dr Jan Trøst Jørgensen holds an MSc degree in pharmacy and a PhD in clinical pharmacy from the Faculty of Pharmaceutical Sciences, University of Copenhagen. He has worked with drug development in biotech and pharmaceutical companies for more than 25 years, and within the last 10 years his focus has been on drug-diagnostic co-development projects within cancer. Dr Jørgensen is a strong supporter of more individualized pharmacotherapy and has published a number of scientific papers on oncology as well as on stratified and personalized medicine.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: killarneybooks, Inagh, CLARE, Irland
Hardcover. Zustand: Very Good. 1st Edition. Hardcover, x + 351 pages, NOT ex-library. Book is clean and bright with unmarked text, free of inscriptions and stamps, firmly bound. External shelfwear; short creases to the lower outer corner of the front board. Issued without a dust jacket. -- The book provides a technical and strategic overview of the role of diagnostic testing in the era of targeted oncology. This edited volume addresses the fundamental shift from broad-spectrum chemotherapy toward stratified treatment regimes based on the specific molecular profile of a patient's tumour. It frames molecular diagnostics - referred to throughout as "pharmacodiagnostics" - as the central mechanism for the implementation of precision medicine, ensuring that the right drug is delivered to the right patient at the right time. The volume details a wide range of analytical methodologies used to identify predictive and prognostic biomarkers. Technical chapters explore established techniques such as immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH), alongside technologies like DNA microarrays and high-throughput genomic platforms. A significant portion of the work is dedicated to the concept of companion diagnostics (CDx), illustrating the co-development process where a drug and its associated test are brought through clinical trials and regulatory approval simultaneously. Specific emphasis is placed on the co-development of trastuzumab and the HercepTest for HER2 testing in breast cancer as the foundational model for this approach. Other case studies, such as estrogen and progesterone receptors and EGFR mutations in lung cancer, demonstrate the practical application of these protocols. Beyond the laboratory, the analysis extends to the regulatory and economic challenges of personalised medicine. It examines the criteria used by agencies such as the FDA and EMA for the validation of biomarkers and the integration of diagnostic data into clinical decision-making. In a contemporary context, the book remains a vital foundational resource for understanding the origins of modern oncology and the technical basis for the targeted therapies and immunotherapy protocols that define current cancer care. Areas of interest: precision oncology, companion diagnostics, pharmacodiagnostics, biomarker validation, targeted therapy. Bestandsnummer des Verkäufers 012259
Anzahl: 1 verfügbar
Anbieter: Basi6 International, Irving, TX, USA
Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Bestandsnummer des Verkäufers ABEOCT25-262671
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Bestandsnummer des Verkäufers ABBB-56774
Anbieter: SMASS Sellers, IRVING, TX, USA
Zustand: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed. Bestandsnummer des Verkäufers SNTNB-56774
Anbieter: Books Puddle, Woodside, NY, USA
Zustand: New. pp. 300. Bestandsnummer des Verkäufers 261415916
Anzahl: 4 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. pp. 300 This item is printed on demand. Bestandsnummer des Verkäufers 6432051
Anzahl: 4 verfügbar
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. pp. 300. Bestandsnummer des Verkäufers 181415910
Anzahl: 4 verfügbar
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
Hardcover. Zustand: New. Brand new book, sourced directly from publisher. Dispatch time is 7-8 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely. Bestandsnummer des Verkäufers 6666-TNFPD-9789814241441
Anzahl: 5 verfügbar
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New. Bestandsnummer des Verkäufers 5985732-n
Anzahl: 10 verfügbar
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Zustand: New. Bestandsnummer des Verkäufers 5985732-n
Anzahl: 10 verfügbar